Skip to content

ANGX ANGX Accounts Receivable, Credit Loss Expense (Reversal)

Accounts Receivable, Credit Loss Expense (Reversal) at other companies

Dolby Laboratories, Inc. logo
Dolby Laboratories, Inc.DLB

Other financials

Income statement

See full
Revenue$115.1M+143%
Gross profit$71.1M+154%
Operating income-$2.7M+92.1%
Net income-$13.8M+63.0%
EPS (diluted)-$0.08+68.0%

Balance sheet

See full
Cash & equivalents$38.9M+10,871%
Total debt$64.8M
Total equity-$10.2M-184%
Total assets$213.1M+20,635%

Cash flow

See full
Operating cash flow$1.9M+119%

Valuation

See full
Market cap$546.03M-74.4%
Enterprise value$571.99M
P/S1.4×

Profitability

See full
Gross margin61.6%
Operating margin-28.8%
Net margin-34.1%

Returns & leverage

See full
Current ratio0.6×+0.5×

Where this comes from

Reported directly by ANGX in its filing.

Tagged under the XBRL concept us-gaap:ProvisionForDoubtfulAccounts.

The official record: ANGX’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about ANGX's accounts receivable, credit loss expense (reversal).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is ANGX's accounts receivable, credit loss expense (reversal)?
ANGX (ANGX) reported accounts receivable, credit loss expense (reversal) of -$90.65K in Q1 2026.
How has ANGX's accounts receivable, credit loss expense (reversal) changed year-over-year?
ANGX's accounts receivable, credit loss expense (reversal) decreased by 255.1% year-over-year, from $58.44K to -$90.65K.
What is the long-term trend for ANGX's accounts receivable, credit loss expense (reversal)?
Over 2 years (2023 to 2025), ANGX's accounts receivable, credit loss expense (reversal) has grown at a -68.7% compound annual growth rate (CAGR), from $2.39M to $233.77K.